Molecular Medicine Tri-Conference | February 15-20, 2015 | San Francisco, CA
February 1, 2015Read moreThe 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.
Orion CEO Magali Haas Featured in Partnering for Cures panel: Unlocking the Mysteries of the Human Brain
November 25, 2014Read moreWhat if we started diagnosing brain disorders based on physiological measures as opposed to the behavioral measures that are currently in use now? This is the provocative question that kicked off the five-person panel discussion at the sixth annual Partnering for Cures, moderated by Kafui Dzirasa of Duke University Medical Center.
Nature Neuroscience presents Focus on Big Data in their November issue
November 6, 2014Read moreNature Neuroscience presents a Focus on Big Data in their November Issue
Orion Alliance Leadership Member Philip De Jager, MD, PhD, Awarded the National MS Society’s 2014 Barancik Prize for Innovation in MS Research
October 23, 2014Read morePhilip L. De Jager, MD, PhD, Neurologist at Brigham and Women’s Hospital and Associate Professor of Neurology at Harvard Medical School, is the 2014 recipient of the Barancik Prize for Innovation in MS Research, an international award established in 2013 to drive progress in multiple sclerosis (MS) research. Dr. De Jager, a clinician and a researcher, was selected for his work in applying powerful analytic approaches to better understand how genes and the environment interact with the goal of developing personalized treatments for MS and, ultimately, disease prevention.
Orion CEO Co-Authors 2014 Report on the Milestones for the US National Plan to Address Alzheimer’s Disease
October 20, 2014Read moreOrion CEO & Founder Magali Haas was a co-author of the Alzheimer’s Association 2014 Report on the Milestones for the US National Plan to Address Alzheimer’s Disease. Read the full report here: http://www.alzheimersanddementia.com/article/S1552-5260(14)02791-5/fulltext
News
Cohen Veterans Bioscience > News
WHO WE ARE
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Learn More Donate
